NLRP3 and metabolic dysfunction-associated steatotic liver disease: Moreover, a reasonable and new mechanism was summarized in this study, namely that inhibiting the activated NLRP3 inflammasome through HSP90 by IQ could mitigate steatohepatitis of NAFLD.